Baidu
map

JAHA:胸段硬膜外麻醉可作为难治性室速的治疗选择

2017-11-22 MedSci MedSci原创

目前,一些调节自主神经系统的新疗法,比如胸段硬膜外麻醉(TEA),在一些小型的系列研究中被证实对难治性室速(VT)有较好的疗效。然而,这是否可以真正作为治疗难治性室速的一个方法尚未阐明。本研究回顾分析了2005年至2016年11例接受胸段硬膜外麻醉的难治性室速患者,对其临床特征、预后结局和治疗管理进行了全面分析。在临床表现上,有7例(64%)患者为持续性室速,3例(27%)患者为多相室速,8例(7

目前,一些调节自主神经系统的新疗法,比如胸段硬膜外麻醉(TEA),在一些小型的系列研究中被证实对难治性室速(VT)有较好的疗效。然而,这是否可以真正作为治疗难治性室速的一个方法尚未阐明。本研究回顾分析了2005年至2016年11例接受胸段硬膜外麻醉的难治性室速患者,对其临床特征、预后结局和治疗管理进行了全面分析。在临床表现上,有7例(64%)患者为持续性室速,3例(27%)患者为多相室速,8例(73%)患者为单相室速,其他潜在的临床表现包括5例(45%)非缺血性心肌病,3例(27%)缺血性心肌病,肥厚型心肌病、Brugada综合征和心脏脂肪瘤各1例(9%)。共有5例(45%)患者对TEA有明显反应,1例(9%)患者对TEA有部分反应,在5例有明显反应的患者中,4例为持续性室速。本研究结果显示,有超过一半的难治性室速患者对胸段硬膜外麻醉是有反应的,TEA可作为难治性室速尤其是持续性室速患者治疗的选择。原始出处:Duc H et al.Thoracic Epidural Anesthesia Can Be Effective for the Short‐Term Management of

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1937136, encodeId=3220193e1361d, content=<a href='/topic/show?id=c06ae363256' target=_blank style='color:#2F92EE;'>#硬膜外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73632, encryptionId=c06ae363256, topicName=硬膜外)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Jun 06 10:12:00 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772702, encodeId=a4c71e7270231, content=<a href='/topic/show?id=871064e139b' target=_blank style='color:#2F92EE;'>#治疗选择#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64713, encryptionId=871064e139b, topicName=治疗选择)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015a38388258, createdName=liye789132264, createdTime=Tue Aug 28 01:12:00 CST 2018, time=2018-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027257, encodeId=88c5202e25707, content=<a href='/topic/show?id=5259e36453f' target=_blank style='color:#2F92EE;'>#硬膜外麻醉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73645, encryptionId=5259e36453f, topicName=硬膜外麻醉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0357291, createdName=xiaoshitou, createdTime=Fri Sep 07 17:12:00 CST 2018, time=2018-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267627, encodeId=ed7a126e62780, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479746, encodeId=adca14e9746ad, content=<a href='/topic/show?id=a9ab4624280' target=_blank style='color:#2F92EE;'>#室速#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46242, encryptionId=a9ab4624280, topicName=室速)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bbc7579990, createdName=124987e8m09暂无昵称, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528413, encodeId=6740152841301, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263361, encodeId=02c2263361e3, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Wed Nov 22 13:29:54 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1937136, encodeId=3220193e1361d, content=<a href='/topic/show?id=c06ae363256' target=_blank style='color:#2F92EE;'>#硬膜外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73632, encryptionId=c06ae363256, topicName=硬膜外)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Jun 06 10:12:00 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772702, encodeId=a4c71e7270231, content=<a href='/topic/show?id=871064e139b' target=_blank style='color:#2F92EE;'>#治疗选择#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64713, encryptionId=871064e139b, topicName=治疗选择)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015a38388258, createdName=liye789132264, createdTime=Tue Aug 28 01:12:00 CST 2018, time=2018-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027257, encodeId=88c5202e25707, content=<a href='/topic/show?id=5259e36453f' target=_blank style='color:#2F92EE;'>#硬膜外麻醉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73645, encryptionId=5259e36453f, topicName=硬膜外麻醉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0357291, createdName=xiaoshitou, createdTime=Fri Sep 07 17:12:00 CST 2018, time=2018-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267627, encodeId=ed7a126e62780, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479746, encodeId=adca14e9746ad, content=<a href='/topic/show?id=a9ab4624280' target=_blank style='color:#2F92EE;'>#室速#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46242, encryptionId=a9ab4624280, topicName=室速)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bbc7579990, createdName=124987e8m09暂无昵称, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528413, encodeId=6740152841301, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263361, encodeId=02c2263361e3, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Wed Nov 22 13:29:54 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1937136, encodeId=3220193e1361d, content=<a href='/topic/show?id=c06ae363256' target=_blank style='color:#2F92EE;'>#硬膜外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73632, encryptionId=c06ae363256, topicName=硬膜外)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Jun 06 10:12:00 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772702, encodeId=a4c71e7270231, content=<a href='/topic/show?id=871064e139b' target=_blank style='color:#2F92EE;'>#治疗选择#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64713, encryptionId=871064e139b, topicName=治疗选择)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015a38388258, createdName=liye789132264, createdTime=Tue Aug 28 01:12:00 CST 2018, time=2018-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027257, encodeId=88c5202e25707, content=<a href='/topic/show?id=5259e36453f' target=_blank style='color:#2F92EE;'>#硬膜外麻醉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73645, encryptionId=5259e36453f, topicName=硬膜外麻醉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0357291, createdName=xiaoshitou, createdTime=Fri Sep 07 17:12:00 CST 2018, time=2018-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267627, encodeId=ed7a126e62780, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479746, encodeId=adca14e9746ad, content=<a href='/topic/show?id=a9ab4624280' target=_blank style='color:#2F92EE;'>#室速#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46242, encryptionId=a9ab4624280, topicName=室速)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bbc7579990, createdName=124987e8m09暂无昵称, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528413, encodeId=6740152841301, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263361, encodeId=02c2263361e3, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Wed Nov 22 13:29:54 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1937136, encodeId=3220193e1361d, content=<a href='/topic/show?id=c06ae363256' target=_blank style='color:#2F92EE;'>#硬膜外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73632, encryptionId=c06ae363256, topicName=硬膜外)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Jun 06 10:12:00 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772702, encodeId=a4c71e7270231, content=<a href='/topic/show?id=871064e139b' target=_blank style='color:#2F92EE;'>#治疗选择#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64713, encryptionId=871064e139b, topicName=治疗选择)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015a38388258, createdName=liye789132264, createdTime=Tue Aug 28 01:12:00 CST 2018, time=2018-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027257, encodeId=88c5202e25707, content=<a href='/topic/show?id=5259e36453f' target=_blank style='color:#2F92EE;'>#硬膜外麻醉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73645, encryptionId=5259e36453f, topicName=硬膜外麻醉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0357291, createdName=xiaoshitou, createdTime=Fri Sep 07 17:12:00 CST 2018, time=2018-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267627, encodeId=ed7a126e62780, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479746, encodeId=adca14e9746ad, content=<a href='/topic/show?id=a9ab4624280' target=_blank style='color:#2F92EE;'>#室速#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46242, encryptionId=a9ab4624280, topicName=室速)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bbc7579990, createdName=124987e8m09暂无昵称, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528413, encodeId=6740152841301, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263361, encodeId=02c2263361e3, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Wed Nov 22 13:29:54 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2017-11-24 zhaohui6731
  5. [GetPortalCommentsPageByObjectIdResponse(id=1937136, encodeId=3220193e1361d, content=<a href='/topic/show?id=c06ae363256' target=_blank style='color:#2F92EE;'>#硬膜外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73632, encryptionId=c06ae363256, topicName=硬膜外)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Jun 06 10:12:00 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772702, encodeId=a4c71e7270231, content=<a href='/topic/show?id=871064e139b' target=_blank style='color:#2F92EE;'>#治疗选择#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64713, encryptionId=871064e139b, topicName=治疗选择)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015a38388258, createdName=liye789132264, createdTime=Tue Aug 28 01:12:00 CST 2018, time=2018-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027257, encodeId=88c5202e25707, content=<a href='/topic/show?id=5259e36453f' target=_blank style='color:#2F92EE;'>#硬膜外麻醉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73645, encryptionId=5259e36453f, topicName=硬膜外麻醉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0357291, createdName=xiaoshitou, createdTime=Fri Sep 07 17:12:00 CST 2018, time=2018-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267627, encodeId=ed7a126e62780, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479746, encodeId=adca14e9746ad, content=<a href='/topic/show?id=a9ab4624280' target=_blank style='color:#2F92EE;'>#室速#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46242, encryptionId=a9ab4624280, topicName=室速)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bbc7579990, createdName=124987e8m09暂无昵称, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528413, encodeId=6740152841301, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263361, encodeId=02c2263361e3, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Wed Nov 22 13:29:54 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1937136, encodeId=3220193e1361d, content=<a href='/topic/show?id=c06ae363256' target=_blank style='color:#2F92EE;'>#硬膜外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73632, encryptionId=c06ae363256, topicName=硬膜外)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Jun 06 10:12:00 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772702, encodeId=a4c71e7270231, content=<a href='/topic/show?id=871064e139b' target=_blank style='color:#2F92EE;'>#治疗选择#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64713, encryptionId=871064e139b, topicName=治疗选择)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015a38388258, createdName=liye789132264, createdTime=Tue Aug 28 01:12:00 CST 2018, time=2018-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027257, encodeId=88c5202e25707, content=<a href='/topic/show?id=5259e36453f' target=_blank style='color:#2F92EE;'>#硬膜外麻醉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73645, encryptionId=5259e36453f, topicName=硬膜外麻醉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0357291, createdName=xiaoshitou, createdTime=Fri Sep 07 17:12:00 CST 2018, time=2018-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267627, encodeId=ed7a126e62780, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479746, encodeId=adca14e9746ad, content=<a href='/topic/show?id=a9ab4624280' target=_blank style='color:#2F92EE;'>#室速#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46242, encryptionId=a9ab4624280, topicName=室速)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bbc7579990, createdName=124987e8m09暂无昵称, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528413, encodeId=6740152841301, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263361, encodeId=02c2263361e3, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Wed Nov 22 13:29:54 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2017-11-24 freve
  7. [GetPortalCommentsPageByObjectIdResponse(id=1937136, encodeId=3220193e1361d, content=<a href='/topic/show?id=c06ae363256' target=_blank style='color:#2F92EE;'>#硬膜外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73632, encryptionId=c06ae363256, topicName=硬膜外)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Jun 06 10:12:00 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772702, encodeId=a4c71e7270231, content=<a href='/topic/show?id=871064e139b' target=_blank style='color:#2F92EE;'>#治疗选择#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64713, encryptionId=871064e139b, topicName=治疗选择)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015a38388258, createdName=liye789132264, createdTime=Tue Aug 28 01:12:00 CST 2018, time=2018-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027257, encodeId=88c5202e25707, content=<a href='/topic/show?id=5259e36453f' target=_blank style='color:#2F92EE;'>#硬膜外麻醉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73645, encryptionId=5259e36453f, topicName=硬膜外麻醉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0357291, createdName=xiaoshitou, createdTime=Fri Sep 07 17:12:00 CST 2018, time=2018-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267627, encodeId=ed7a126e62780, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479746, encodeId=adca14e9746ad, content=<a href='/topic/show?id=a9ab4624280' target=_blank style='color:#2F92EE;'>#室速#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46242, encryptionId=a9ab4624280, topicName=室速)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bbc7579990, createdName=124987e8m09暂无昵称, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528413, encodeId=6740152841301, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Fri Nov 24 04:12:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263361, encodeId=02c2263361e3, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Wed Nov 22 13:29:54 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2017-11-22 惠映实验室

    学习了.谢谢.

    0

相关资讯

JAHA:交感神经活动并不是黑种肥胖患者引起高血压的原因

黑种女性在美国的肥胖和高血压发病率是最高的。既往研究显示,在白种肥胖患者中,交感神经的激活是导致高血压的重要原因之一,而这种机制在黑种肥胖患者中尚未阐明。本研究纳入了42例肥胖女性(16例为白种人,BMI为36±4 kg/m2,其中44%患有高血压;26例为黑种人,BMI为35±4 kg/m2,高血压占46%),在本研究开始前,所有患者抗高血压药停止了2周。静息状态下的交感神经活动通过肌肉交感神经

JBC:糖尿病前期:警惕这几个指标可以预防糖尿病 !

悉尼大学Charles Perkins研究中心的研究人员已经确定了三种精确指示胰岛素抵抗的特定分子,即糖尿病前期 - 代谢综合征的主要预测指标,包括腹部肥胖,高血压和高血糖水平。

JAHA:心电图提示左室肥大的高血压患者预后明显更差

高血压患者伴有左室肥大(LVH)心电图表现的心源性死亡率和发病率均更高,但是单一的心电图诊断标准可能会低估了心血管风险。本研究纳入了9193名随机分配至氯沙坦或阿替洛尔治疗组的高血压患者,通过康奈尔法和/或Sokolow‐Lyon法对患者左室肥大心电图进行诊断,在4.8±0.9年的随访时间里,对患者的卒中、心梗、心源性死亡、复合结局和全因死亡率与患者心电图的关系进行评估。研究开始时,将患者根据每个

Kidney int:LDL、炎症以及心血管风险之间是一种怎样的关系?

一些炎症标志物,包括血浆C-反应蛋白(CRP),与心血管疾病的风险增加有关,并且有研究者认为这种关联存在着因果关系。然而,炎症与心血管疾病之间的关系尚未在慢性肾病患者中进行深入研究。近期,一项发表在杂志Kidney int上的研究旨在评估这两者之间的关系。研究者们使用心脏和肾脏保护研究(SHARP)的数据评估了循环系统汇总CRP和LDL胆固醇水平之间的关系以及血管和非血管结果的风险。主要血管事件被

JAHA:血压>150/95 mm Hg的患者推荐使用联合药物治疗

根据高血压患者不同情况的分层,不同指南对初始联合治疗或初始单药治疗的推荐各不相同,本研究的目的旨在比较评估这些疗法的有效性和可接受性。本次随机双盲对照临床研究纳入了605名18-79岁尚未接受治疗的收缩压≥150mmHg或舒张压≥95mmHg的高血压患者,随访时间为1年。在前期(0-16周),所有患者被随机分至初始单药治疗组(氯沙坦50 - 100毫克或氢氯噻嗪-12.5-25毫克)或初始联合治疗

Diabetes Care:糖尿病患者因心血管疾病而住院的现状如何?

美国糖尿病人群中记录的心脏病发作和卒中住院的患者逐步减少。近期,一项发表在杂志Diabetes Care上的研究将趋势分析扩展到其他心血管疾病(CVD)中,包括不同类型的中风。此项研究使用了1998 - 2014年全国住院病例样本数据,估算了急性冠脉综合征(ACS)(ICD-9代码410-411),心律失常(427),心力衰竭(428),出血性脑卒中(430-432)或缺血性中风(433.x1,4

Baidu
map
Baidu
map
Baidu
map